Hypertriglyceridemia in an outpatient department--Significance as an atherosclerotic risk factor

M Scholz1, S Tselmin1, S Fischer1

  • 1Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Fetscherstr. 74, 01307 Dresden, Germany.

Insights

Elevated triglycerides (hypertriglyceridemia) increase cardiovascular event risk, especially with metabolic vascular syndrome. Lipid-lowering therapy effectively reduced cardiovascular events and pancreatitis incidence in patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • The link between high triglycerides (HTG) and cardiovascular diseases (CVD) is debated.
  • This study examines cardiovascular events (CVE) and pancreatitis in HTG patients.

Purpose of the Study:

  • To analyze CVE and pancreatitis incidence in HTG patients.
  • To evaluate therapeutic regimens for HTG.
  • To assess the impact of HTG severity and co-existing metabolic vascular syndrome (MVS) on outcomes.

Main Methods:

  • Retrospective analysis of 232 HTG patients (183 mild, 49 severe).
  • Subgroup analysis by gender, MVS presence, and lipid levels.
  • Evaluation of therapeutic interventions, including omega-3 fatty acids and fibrates.

Main Results:

  • CVE occurred at a younger age compared to general population rates.
  • TG levels, CVE, and pancreatitis rates decreased with therapy.
  • Non-compliant patients with persistent severe HTG faced high pancreatitis risk.

Conclusions:

  • No direct TG-CVE link found, but HTG combined with MVS is highly dangerous.
  • Lipid-lowering therapy effectively reduced CVE and pancreatitis.
  • Patient compliance is crucial for managing severe HTG and preventing complications.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
603
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
871
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.1K
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
441
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.0K